Acutaas Chemicals Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACUTAAS.BO | AARTIIND.NS | ATUL.BO | 4187.T | VINATIORGA.BO | ANURAS.BO | |
|---|---|---|---|---|---|---|
| Market cap | 311.93B | 160.80B | 155.42B | 78.10B | 104.62B | 131.17B |
| P/E (TTM) | 68.8 | 27.1 | 26.2 | 9.0 | 25.4 | 74.9 |
| Forward P/E | 48.4 | 22.0 | 20.7 | 22.1 | 18.6 | 28.9 |
| Price/book | 16.8 | 2.6 | 2.6 | 1.4 | 3.2 | 3.9 |
| Dividend yield | 0.07% | 0.22% | 0.40% | 2.39% | 0.85% | 0.13% |
| 1-year change | +121.17% | +14.04% | +2.40% | +11.76% | −40.40% | +6.59% |
| Today | +0.86% | −0.95% | +2.40% | −8.13% | +1.24% | +0.67% |
The closest companies by business and industry (Specialty Chemicals). Prices may be delayed up to 20 min.
Latest news
All ACUTAAS.BO news ›Acutaas Chemicals Q1 FY27 Results: Revenue Climbs 59%
Know Acutaas Chemicals inside out Operating profit was ₹113.07 crore in Q1 FY27, more than double ₹50.91 crore reported in Q1 FY26. EBITDA rose to ₹114.87 crore from ₹66.84 crore a year earlier. The company’s reported EBITDA margin was…
Acutaas Chemicals raises FY27 growth outlook to about 30%
Acutaas Chemicals Limited raised its FY27 revenue-growth guidance to about 30% from 25% and its EBITDA margin outlook to 38%-40%, after Q2 FY27 revenue increased 42.7% year on year to Rs 436.9 crore and EBITDA margin reached 40.3%.…
Acutaas Chemicals Q2 profit rises 71.4%, lifts FY27 outlook
Acutaas Chemicals Limited reported Q2 FY27 profit of ₹123.1 crore, up 71.4% year-on-year, as revenue grew 42.7% to ₹436.9 crore and prompted the company to raise its FY27 revenue-growth guidance to about 30%. Know Acutaas Chemicals inside…
Acutaas Chemicals appoints new Senior Management Personnel and revises reporting structure
Acutaas Chemicals appoints new SMP InvestyWise Acutaas Chemicals appoints new Senior Management Personnel and revises reporting structure Acutaas Chemicals Limited announced the appointment of Dr. Ashish Kumar Pandey as Assistant Vice…
Buy Acutaas Chemicals; target of Rs 4693: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Acutaas Chemicals has recommended buy rating on the stock with a target price of Rs 4693 in its research report dated October 27, 2026. Buy Acutaas Chemicals; target of Rs 4693: Prabhudas Lilladher…
Acutaas Chemicals Reports Robust Q2 FY27 Earnings; Net Profit Rises 71.4% To ₹123.1 Crore, Strong Revenue Growth Continues
Mumbai: Acutaas Chemicals Limited on October 27, 2026, announced its financial results for the quarter and half year ended September 30, 2026. The company’s consolidated net profit for Q2 FY27 stood at ₹123.1 crore, a 71.4 per cent…
Acutaas Chemicals Limited: Completes 100% Acquisition of Enchem Ami Organics
InvestyWise Acutaas Chemicals Limited: Completes 100% Acquisition of Enchem Ami Organics Acutaas Chemicals Limited has announced the completion of its acquisition of 100% of the equity share capital of Enchem Ami Organics
More from 1 other outlet
Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price
Pharma stocks to buy: Sun Pharma, Ajanta Pharma, Ipca Labs, Mankind Pharma and Acutaas Chemicals are likely to be key pharmaceutical companies to deliver strong results for the second quarter of the financial year 2026-27, according to…
Acutaas Chemicals targets ₹1,000 crore CDMO revenue in FY27
Acutaas Chemicals Limited said on October 27, 2026, that it expects contract development and manufacturing organisation (CDMO) revenue of ₹1,000 crore in FY27, one year before its prior FY28 target, based on existing and new contracts; Q2…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- multibagg.ai4
- investywise.com2
- businessupturn.com1
- freepressjournal.in1
- livemint.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.